Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-10946-2.pdf
Reference23 articles.
1. Postow, M. A., Callahan, M. K. & Wolchok, J. D. Immune Checkpoint Blockade in Cancer Therapy. Journal of Clinical Oncology 33, 1974–1982, doi: 10.1200/JCO.2014.59.4358 (2015).
2. Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571, doi: 10.1038/nature13954 (2014).
3. Bhardwaj, G., Agrawal, A. & Tyagi, R. Combination therapies or standalone interventions? Innovation options for pharmaceutical firms fighting cancer. International Journal of Innovation Management 19, 1540003, doi: 10.1142/s1363919615400034 (2015).
4. La-Beck, N. M., Jean, G. W., Huynh, C., Alzghari, S. K. & Lowe, D. B. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35, 963–976, doi: 10.1002/phar.1643 (2015).
5. Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Science Translational Medicine 8, 328rv324–328rv324, doi: 10.1126/scitranslmed.aad7118 (2016).
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The multiple arrays of a PD1-derived peptide on chromatin specifically bind to PD-L1 and induce doxorubicin resistance in cancer cell lines;Biochemical and Biophysical Research Communications;2024-02
2. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion;Frontiers in Immunology;2024-01-03
3. Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome;Frontiers in Immunology;2023-10-02
4. Peptides as multifunctional players in cancer therapy;Experimental & Molecular Medicine;2023-06-01
5. Paeonol inhibits melanoma growth by targeting PD1 through upregulation of miR-139-5p;Biochemical and Biophysical Research Communications;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3